Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Lascoux

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
AIDS Research and Human Retroviruses|June 22, 2010
Short communication: evidence of HIV type 1 complex and second generation recombinant strains among patients infected in 1997-2007 in France: ANRS CO06 PRIMO CohortJulie Galimand, Pierre Frange, Christine Rouzioux, et al.
AIDS (London, England)|July 9, 2015
Rates and determinants of hepatitis B 'e' antigen and hepatitis B surface antigen seroclearance during long-term follow-up of patients coinfected with HIV and hepatitis B virusAnders Boyd, Joël Gozlan, Patrick Miailhes, et al.
The Journal of Antimicrobial Chemotherapy|August 30, 2021
Persistent HBV replication and serological response during up to 15 years of tenofovir-based antiretroviral therapy in HIV/HBV-coinfected patients: a multicentre prospective cohort studyLorenza N C Dezanet, Patrick Miailhes, Caroline Lascoux-Combe, et al.
Medicine|March 9, 2017
Nonorgan-specific autoantibodies in HIV-infected patients in the HAART eraLaura Iordache, Djaouida Bengoufa, Olivier Taulera, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 23, 2021
Profiles of liver fibrosis evolution during long-term tenofovir treatment in HIV-positive patients coinfected with hepatitis BLorenza N C Dezanet, Patrick Miailhes, Caroline Lascoux-Combe, et al.
Journal of Hepatology|April 29, 2009
Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patientsJulie Bottero, Karine Lacombe, Jérôme Guéchot, et al.
Antiviral Therapy|November 3, 2010
Liver fibrosis changes in HIV-HBV-coinfected patients: clinical, biochemical and histological effect of long-term tenofovir disoproxil fumarate useAnders Boyd, Elisabeth Lasnier, Jean Michel Molina, et al.
Blood|September 28, 2013
Maraviroc-induced decrease in circulating bacterial products is not linked to an increase in immune activation in HIV-infected individualsChristina Psomas, Jean-Philippe Lavigne, Claudine Barbuat, et al.
Journal of Lipid Research|January 10, 2015
Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAARTPetra El Khoury, Mathilde Ghislain, Elise F Villard, et al.
American Journal of Respiratory and Critical Care Medicine|October 13, 2007
Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy eraOlivier Sitbon, Caroline Lascoux-Combe, Jean-François Delfraissy, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
AIDS Research and Human Retroviruses|June 22, 2010
Short communication: evidence of HIV type 1 complex and second generation recombinant strains among patients infected in 1997-2007 in France: ANRS CO06 PRIMO CohortJulie Galimand, Pierre Frange, Christine Rouzioux, et al.
AIDS (London, England)|July 9, 2015
Rates and determinants of hepatitis B 'e' antigen and hepatitis B surface antigen seroclearance during long-term follow-up of patients coinfected with HIV and hepatitis B virusAnders Boyd, Joël Gozlan, Patrick Miailhes, et al.
The Journal of Antimicrobial Chemotherapy|August 30, 2021
Persistent HBV replication and serological response during up to 15 years of tenofovir-based antiretroviral therapy in HIV/HBV-coinfected patients: a multicentre prospective cohort studyLorenza N C Dezanet, Patrick Miailhes, Caroline Lascoux-Combe, et al.
Medicine|March 9, 2017
Nonorgan-specific autoantibodies in HIV-infected patients in the HAART eraLaura Iordache, Djaouida Bengoufa, Olivier Taulera, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 23, 2021
Profiles of liver fibrosis evolution during long-term tenofovir treatment in HIV-positive patients coinfected with hepatitis BLorenza N C Dezanet, Patrick Miailhes, Caroline Lascoux-Combe, et al.
Journal of Hepatology|April 29, 2009
Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patientsJulie Bottero, Karine Lacombe, Jérôme Guéchot, et al.
Antiviral Therapy|November 3, 2010
Liver fibrosis changes in HIV-HBV-coinfected patients: clinical, biochemical and histological effect of long-term tenofovir disoproxil fumarate useAnders Boyd, Elisabeth Lasnier, Jean Michel Molina, et al.
Blood|September 28, 2013
Maraviroc-induced decrease in circulating bacterial products is not linked to an increase in immune activation in HIV-infected individualsChristina Psomas, Jean-Philippe Lavigne, Claudine Barbuat, et al.
Journal of Lipid Research|January 10, 2015
Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAARTPetra El Khoury, Mathilde Ghislain, Elise F Villard, et al.
American Journal of Respiratory and Critical Care Medicine|October 13, 2007
Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy eraOlivier Sitbon, Caroline Lascoux-Combe, Jean-François Delfraissy, et al.
Pageof 8